3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

6 June, 2019 | General

The arrangement covers process transfer, process development and GMP manufacture of Affibody’s candidate 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody. […]

Large-scale manufacturing process for Strangvac now secured

2 April, 2019 | General

We are so glad to be part of such an exciting project with the Swedish company INTERVACC, who we are working with on manufacturing of Strangvac® including the large-scale production of the vaccine against equine strangles. The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the […]

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

11 March, 2019 | General

Pamplona, 11th of March, 2019. 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xenikos) that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®. 3P and Xenikos started their collaboration in 2015 […]

Expansion of analytical capacities by 3P Biopharmaceuticals

27 February, 2019 | General

3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.   The 3P Analytical Development Area is one of the company’s core competences and is crucial to the state-of-the-art technologies as well as services it provides to the clients.   The development of analytical methods is an essential activity in any process development and manufacturing […]

Merry Christmas and Happy New Year 2019!

18 December, 2018 | General

Our entire team wishes you a Merry Christmas and our Warm Wishes for a wonderful Holiday Season. Our very best wishes for a happy new year filled with health, happiness, and spectacular success!

Welcome to our new website

11 December, 2018 | General

We are pleased to announce the launch of our newly revamped website which creates a user-friendly browsing experience. The new structure provides a more interactive experience, allowing our partners to easily find the information they are looking for. In addition to aesthetically re-designing our website, we have also refined our services category structure to provide […]

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

5 December, 2018 | General

3P has implemented a new design in its manufacturing plant increasing its capacities and incorporating innovative equipment and state of the art technologies. The investments made in infrastructure and equipment during 2018 exceed 5 million euros. 3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that […]

Permanent award in the form of the Reconcilia Label

4 December, 2018 | General

Permanent award in the form of the Reconcilia Label. We are proud to have received a permanent award in the form of the Reconcilia Label. Last 27th November, the AMEDNA (Navarre Business Women´s Association) recognized those companies that are engaged in the reconciliation of professional, family and personal life. We have obtained the permanent recognition […]

[:en]Annual bioProcessUK Conference 2018[:]

12 November, 2018 | Events, General

[:en] Meet us at the Annual bioProcessUK Conference 2018! The BIA is organizing the 15th Annual bioProcessUK Conference that is taking place in Edinburgh on 20-22 November 2018. The conference goes from strength to strength and 2017 saw over 285 delegates from 160 leading organisations attend to hear the latest news/updates and developments within the […]

Spanish Biotech Industry: 3P selected as one of the Main Success Stories

31 October, 2018 | General

3P Biopharmaceuticals has been selected as one of the Main Success Stories in the Spanish biotech sector in the last 10 years. ASEBIO presented last week this report where are described a total of 20 success cases of the Biotechnology Sector in Spain in the last 10 years. These success stories have been carefully selected […]